Axena Health, Inc., a medical device company focused on female pelvic health, has announced the development of a machine learning model that could help clinicians create personalized treatments for female pelvic floor disorders. Researchers from Massachusetts General Hospital, the Massachusetts…
Hesperos, a leader in human biology recreation with its Human-on-a-Chip® platform, has made a significant advancement by developing a human induced pluripotent stem cell (iPSC)-derived model of peripheral myelination. This research, published in ACS Biomaterials, was conducted in collaboration with…
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical-stage gene editing company using its proprietary ARCUS® platform for advanced in vivo gene editing therapies, announced a poster presentation at the European Society of Gene & Cell Therapy (ESGCT) 31st Annual Congress, taking…
PharmaJet®, a company focused on enhancing injectable performance with its needle-free technology, has announced the results of an implementation study in Nigeria. This study evaluated the impact of administering the intradermal fractional inactivated poliovirus vaccine (fIPV) using the Tropis® ID…
Upfront Healthcare’s collaboration with Prisma Health, which has successfully engaged nearly one million patients, is featured in the latest issue of The Healthcare Administration Leadership & Management (HALM) Journal. Published by the American Association for Physician Leadership (AAPL), this journal…
BlueWind Medical, Ltd., a pioneer in implantable Tibial NeuroModulation (iTNM) and the creator of the Revi® System, has announced the presentation of new two-year data from its OASIS pivotal study. These findings were shared at the American Urogynecologic Society (AUGS)…
Simulations Plus, Inc. (Nasdaq: SLP), a top provider of biosimulation and performance solutions for the biopharma industry, has announced its financial results for the fourth quarter and fiscal year 2024, ending August 31, 2024. Fourth Quarter 2024 Financial Highlights (vs.…
Rubedo Life Sciences, a biopharmaceutical company dedicated to developing advanced therapies targeting senescent cells linked to age-related diseases, has announced the opening of its European headquarters and clinical operations in Milan. This expansion precedes the company’s inaugural in-human Phase 1…
8×8, Inc. (NASDAQ: EGHT), a prominent provider of business communications, customer experience (CX), and CPaaS platforms, has announced that CareMonitor has successfully implemented 8×8 CPaaS to enhance critical patient interactions. The integration of 8×8 Jitsi as a Service (JaaS) and…
Modivcare Inc. (Nasdaq: MODV), a technology-enabled healthcare services company focused on improving health outcomes through integrated supportive care solutions, has successfully completed an 18-month Remote Patient Monitoring (RPM) pilot program. This initiative, conducted in collaboration with the Michigan Center for…
Merck (NYSE: MRK), known as MSD outside the U.S. and Canada, has announced that the CDC’s Advisory Committee on Immunization Practices (ACIP) has voted to update the pneumococcal vaccination guidelines for adults. The committee recommends CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine)…
A recent study published in the Annals of Hepatology investigated the feasibility of using the AMRA® MAsS Scan, powered by the FDA-cleared AMRA® Profiler 4 device, to assess muscle composition in patients with end-stage liver disease (ESLD). This research is…